The involvement of ABCA1 in the pathogenesis of atherosclerosis, through the function of reverse cholesterol transport, as well as participation in the development of lung emphysema through the regulation of angiogenesis, indicate an important contribution of the transporter to various mechanisms of COPD development. Here, ABCA1 is linked to chronic obstructive pulmonary disease.